Clinical Trial Update: Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower Extremities [NA]

View source ↗

Summary

A clinical trial evaluating Integuseal as a microbial sealant in lower-extremity arterial bypass surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• InteguSeal

Snippet

Sponsor: Rijnstate Hospital | Conditions: Arterial Obstructive Diseases | NA | Status: TERMINATED